OTC Pravachol Self-Selection Among Rx Users Needs More Study - NDAC

The reasons individuals switch from taking Rx cholesterol-lowering agents to OTC Pravachol (pravastatin) in actual use studies should be the subject of additional examination, FDA advisory committee members suggested to Bristol-Myers Squibb July 14.